CASI PHARMACEUTICALS, INC. Foreign Currency Transaction Gain (Loss), before Tax
CASI PHARMACEUTICALS, INC. (CASIF) reported Foreign Currency Transaction Gain (Loss), before Tax of -$2.16 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-05-15
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2025-12-31 | -$2.16M 20-F · filed 2026-05-15 |
| 2024-12-31 | -$192.00K 20-F · filed 2026-05-15 |
| 2023-12-31 | $200.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | $3.24M 20-F · filed 2025-03-31 |
| 2021-12-31 | $321.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | -$1.25M 20-F · filed 2023-04-26 |